| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $512.7M | -3.5% |
| Cost of Revenue | $134.6M | -0.2% |
| R&D Expense | $55.6M | -8.4% |
| SG&A Expense | $80.6M | -12.7% |
| Operating Income | -$89.5M | -28.5% |
| Interest Expense | $58.5M | -7.9% |
| Pre-tax Income | -$153.5M | -20.3% |
| Income Tax | -$13.7M | -138.9% |
| Net Income | -$139.8M | -14.7% |
| EPS (Basic) | -$16.27 | -9.4% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.8M | +0.0% |
| Accounts Receivable | $175.0M | -2.2% |
| Current Assets | $333.0M | +0.1% |
| Total Assets | $963.1M | -12.9% |
| Current Liabilities | $373.0M | -1.1% |
| Long-term Debt | $570.8M | -0.4% |
| Stockholders' Equity | -$30.2M | -132.2% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.1M | -16.4% |
| Capital Expenditures | $1.8M | +10.2% |
| Investing Cash Flow | -$18.6M | -1.1% |
| Financing Cash Flow | -$8.1M | +84.4% |
| Free Cash Flow | $23.3M | -17.9% |